RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
BERRUTI A
Collezione AOU San Luigi di Orbassano
Items : 160
Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2024 Jul;205:114088. doi: 10.1016/j.ejca.2024.114088. Epub 2024 Apr 26.
2024
ASL Biella
AOU San Luigi di Orbassano
Volante M; Palermo F; Sigala S; Rossini E; Saba L; Perotti P; Laganà M; Puglisi S; Cosentini D; Basile V; Grosso E; Tomaiuolo P; Scatolini M; Grisanti S; Berruti A; Terzolo M;
Optimising Radioligand Therapy for Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumours: Expert Opinion from an Italian Multidisciplinary Group. in Advances in therapy / Adv Ther. 2024 Jan;41(1):113-129. doi: 10.1007/s12325-023-02714-8. Epub 2023 Nov 21.
2024
AOU San Luigi di Orbassano
AO Ordine Mauriziano
Lastoria S; Stasi M; Volante M; Seregni E; Santimaria M; Schillaci O; Panzuto F; Milione M; Grimaldi F; Giordano A; D'Onofrio M; Ferone D; Bartolomei M; Berruti A; Foglia E; Fazio N; Falconi M;
Corrigendum to "Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology volume 31 (2020) 1476-1490]. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2023 Jul;34(7):631. doi: 10.1016/j.annonc.2022.12.006. Epub 2022 Dec 21.
2023
AOU San Luigi di Orbassano
Berruti A; Terzolo M; de Krijger R; Porpiglia F; Haak HR; Fouchardiere C; Baudin E; Eisenhofer G; Assie G; Fassnacht M;
Eighth International Adrenal Cancer Symposium Brescia, Italy, September 30 to October 1-2, 2021. in Endocrine / Endocrine. 2022 Sep;77(3):409-410. doi: 10.1007/s12020-022-03147-z.
2022
ASL Torino 4
AOU San Luigi di Orbassano
Filetti S; Terzolo M; Berruti A;
Progression of Vertebral Fractures in Patients with Adrenocortical Carcinoma Undergoing Mitotane Therapy. in The Journal of clinical endocrinology and metabolism / J Clin Endocrinol Metab. 2022 Apr 19;107(5):e2167-e2176. doi: 10.1210/clinem/dgab899.
2022
ASL Torino 4
AOU San Luigi di Orbassano
Baudin E; Terzolo M; Gasparotti R; Al Ghuzlan A; Maroldi R; Valsecchi C; Pedersini R; Lamartina L; Zamparini M; Deschamps F; Laganà M; Frigerio M; Hadoux J; Libè R; Grisanti S; Cosentini D; Berruti A;
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma. in ESMO open / ESMO Open. 2022 Apr;7(2):100422. doi: 10.1016/j.esmoop.2022.100422. Epub 2022 Mar 7.
2022
ASL Torino 4
AOU San Luigi di Orbassano
Sigala S; Tiberio GAM; Terzolo M; Canu L; Turla A; Gianoncelli A; Ferrari VD; Zamparini M; Abate A; Ambrosini R; Cosentini D; Grisanti S; Laganà M; Berruti A;
Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study. in British journal of cancer / Br J Cancer. 2021 Oct;125(9):1233-1238. doi: 10.1038/s41416-021-01513-8. Epub 2021 Aug 16.
2021
AOU San Luigi di Orbassano
Kimpel O; Bedrose S; Megerle F; Berruti A; Terzolo M; Kroiss M; Mai K; Dekkers OM; Habra MA; Fassnacht M;
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study. in European journal of endocrinology / Eur J Endocrinol. 2021 Nov 30;186(1):25-36. doi: 10.1530/EJE-21-0510.
2021
ASL Torino 4
AOU San Luigi di Orbassano
Cosentini D; Berhane S; Altieri B; Elhassan YS; Calabrese A; Haissaguerre M; Kastelan D; Fragoso MCBV; Bertherat J; Al Ghuzlan A; Haak H; Boudina M; Canu L; Loli P; Sherlock M; Kimpel O; Laganà M; Sitch AJ; Kroiss M; Arlt W; Terzolo M; Berruti A; Deeks JJ; Libé R; Fassnacht M; Ronchi CL;
Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and Histology. in European urology focus / Eur Urol Focus. 2021 May;7(3):644-652. doi: 10.1016/j.euf.2020.05.003. Epub 2020 May 23.
2021
AOU San Luigi di Orbassano
ASL Città di Torino
Pecoraro A; Palumbo C; Knipper S; Rosiello G; Luzzago S; Deuker M; Tian Z; Shariat SF; Simeone C; Briganti A; Saad F; Berruti A; Antonelli A; Karakiewicz PI;
Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis. in Endocrine-related cancer / Endocr Relat Cancer. 2021 Jul 5;28(8):593-604. doi: 10.1530/ERC-21-0123.
2021
AOU San Luigi di Orbassano
Gurizzan C; Zamparini M; Volante M; Tovazzi V; Amoroso V; Consoli F; Petrelli F; Grisanti S; Bossi P; Berruti A;
ENSAT registry-based randomized clinical trials for adrenocortical carcinoma. in European journal of endocrinology / Eur J Endocrinol. 2021 Feb;184(2):R51-R59. doi: 10.1530/EJE-20-0800.
2021
AOU San Luigi di Orbassano
Quinkler M; Trofimiuk-Müldner M; Bancos I; Shafigullina Z; Vroonen L; Morelli V; Aylwin S; Van Slycke S; de Krijger R; Feelders R; Rodien P; Loli P; Dennedy MC; Vantyghem MC; Sherlock M; De Martino MC; Bugalho MJ; Romero MT; Nowak KM; Newell-Price J; Paiva I; Bourdeau I; Assié G; Arnaldi G; Yiannakopoulou E; Osher E; Kastelan D; Canu L; Kiriakopoulos A; et alii...
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy. in Endocrine / Endocrine. 2021 Apr;72(1):20-23. doi: 10.1007/s12020-020-02569-x. Epub 2021 Jan 5.
2021
AOU San Luigi di Orbassano
Berruti A; Sigala S; Terzolo M; Volta AD; Ferrari VD; Laganà M; Grisanti S; Cosentini D;
Unwanted Hormonal and Metabolic Effects of Postoperative Adjuvant Mitotane Treatment for Adrenocortical Cancer. in Cancers / Cancers (Basel). 2020 Sep 14;12(9):2615. doi: 10.3390/cancers12092615.
2020
AOU San Luigi di Orbassano
Terzolo M; Reimondo G; Berruti A; Perotti P; Pia A; Calabrese A; Puglisi S; Basile V;
On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2020 Oct;31(10):1415-1416. doi: 10.1016/j.annonc.2020.06.005. Epub 2020 Jun 18.
2020
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
Zucali P; Tucci M; Verri E; Procopio G; Mucciarini C; Mosca A; Massari F; Fratino L; Masini C; Fornarini G; Ermacora P; Donini M; Buti S; Ceresoli GL; Bortolus R; Berruti A; Baldessari C; Buttigliero C; Zagonel V; Caffo O;
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2020 Nov;31(11):1476-1490. doi: 10.1016/j.annonc.2020.08.2099. Epub 2020 Aug 27.
2020
AOU San Luigi di Orbassano
Terzolo M; de Krijger R; Porpiglia F; Haak HR; de la Fouchardiere C; Baudin E; Eisenhofer G; Assie G; Fassnacht M; Berruti A;
Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients. in Journal of geriatric oncology / J Geriatr Oncol. 2020 May;11(4):718-723. doi: 10.1016/j.jgo.2019.06.005. Epub 2019 Jun 27.
2020
AOU San Luigi di Orbassano
ASL Città di Torino
Knipper S; Palumbo C; Dzyuba-Negrean C; Pecoraro A; Rosiello G; Tian Z; Shariat SF; Simeone C; Briganti A; Saad F; Berruti A; Antonelli A; Karakiewicz PI;
Treatment With 90Y/177Lu-DOTATOC in Patients With Metastatic Adrenocortical Carcinoma Expressing Somatostatin Receptors. in The Journal of clinical endocrinology and metabolism / J Clin Endocrinol Metab. 2020 Mar 1;105(3):dgz091. doi: 10.1210/clinem/dgz091.
2020
AOU San Luigi di Orbassano
ASL Città di Torino
Versari A; Terzolo M; Volante M; Tiberio GMA; Bertagna F; Dalla Volta A; Laganà M; Morandi A; Albano D; Rapa I; Cosentini D; Basile V; Filice A; Grisanti S; Berruti A;
Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy. in Surgical oncology / Surg Oncol. 2020 Mar;32:8-13. doi: 10.1016/j.suronc.2019.10.014. Epub 2019 Oct 25.
2020
AOU San Luigi di Orbassano
ASL Città di Torino
Knipper S; Palumbo C; Pecoraro A; Rosiello G; Luzzago S; Deuker M; Tian Z; Shariat SF; Simeone C; Briganti A; Saad F; Berruti A; Antonelli A; Karakiewicz PI;
Differences in short-term outcomes between open versus robot-assisted radical cystectomy in frail malnourished patients. in European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology / Eur J Surg Oncol. 2020 Jul;46(7):1347-1352. doi: 10.1016/j.ejso.2020.03.204. Epub 2020 Mar 14.
2020
AOU San Luigi di Orbassano
ASL Città di Torino
Knipper S; Palumbo C; Pecoraro A; Rosiello G; Luzzago S; Deuker M; Tian Z; Shariat SF; Simeone C; Briganti A; Saad F; Berruti A; Antonelli A; Karakiewicz PI;
Contemporary Cytoreductive Nephrectomy Provides Survival Benefit in Clear-cell Metastatic Renal Cell Carcinoma. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2020 Dec;18(6):e730-e738. doi: 10.1016/j.clgc.2020.05.009. Epub 2020 May 20.
2020
AOU San Luigi di Orbassano
ASL Città di Torino
Mistretta FA; Palumbo C; Knipper S; Pecoraro A; Tian Z; Dzyuba-Negrean C; Shariat SF; Saad F; Simeone C; Berruti A; Briganti A; Kapoor A; Antonelli A; Karakiewicz PI;
Bladder cancer incidence rates and trends in young adults aged 20-39 years. in Urologic oncology / Urol Oncol. 2020 Dec;38(12):934.e11-934.e19. doi: 10.1016/j.urolonc.2020.06.009. Epub 2020 Jul 9.
2020
AOU San Luigi di Orbassano
ASL Città di Torino
Pecoraro A; Palumbo C; Rosiello G; Luzzago S; Deuker M; Stolzenbach F; Tian Z; Shariat SF; Simeone C; Briganti A; Saad F; Berruti A; Antonelli A; Karakiewicz PI;
Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study. in The Journal of clinical endocrinology and metabolism / J Clin Endocrinol Metab. 2020 Aug 1;105(8):dgaa293. doi: 10.1210/clinem/dgaa293.
2020
AOU San Luigi di Orbassano
Fassnacht M; Sbiera S; Paiva I; Della Casa S; Volante M; Canu L; Berruti A; Ronchi CL; Megerle F; Zerbini MCN; Schreiner J; Kircher S; Landwehr LS; Basile V; Lacombe AMF; Altieri B; Weigand I; Fragoso MCBV; Terzolo M; Kroiss M;
Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years. in Cancer epidemiology / Cancer Epidemiol. 2020 Aug;67:101762. doi: 10.1016/j.canep.2020.101762. Epub 2020 Jun 22.
2020
AOU San Luigi di Orbassano
ASL Città di Torino
Pecoraro A; Palumbo C; Rosiello G; Luzzago S; Deuker M; Stolzenbach F; Tian Z; Shariat SF; Simeone C; Briganti A; Saad F; Berruti A; Antonelli A; Karakiewicz PI;
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells. in Cancers / Cancers (Basel). 2020 Apr 9;12(4):928. doi: 10.3390/cancers12040928.
2020
AOU San Luigi di Orbassano
Memo M; Terzolo M; Grisanti S; Laganà M; Hantel C; Benetti D; Tiberio GAM; Fragni M; Cosentini D; Bonini SA; Abate A; Rossini E; Berruti A; Sigala S;
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. in Cancers / Cancers (Basel). 2020 Apr 10;12(4):941. doi: 10.3390/cancers12040941.
2020
AOU San Luigi di Orbassano
Tiberio GAM; Sigala S; Terzolo M; Poliani PL; Palumbo C; Volta AD; Ambrosini R; Sardini C; Lazzari B; Ferrari VD; Cosentini D; Grisanti S; Laganà M; Berruti A;
Adrenocortical Carcinoma Xenograft in Zebrafish Embryos as a Model To Study the In Vivo Cytotoxicity of Abiraterone Acetate. in Endocrinology / Endocrinology. 2019 Nov 1;160(11):2620-2629. doi: 10.1210/en.2019-00152.
2019
AOU San Luigi di Orbassano
Berruti A; Memo M; Terzolo M; Bono F; Zizioli D; Basnet RM; Abate A; Rossini E; Bertuzzi M; Fragni M; Guarienti M; Gianoncelli A; Sigala S;
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: a multicenter retrospective study. in European journal of endocrinology / Eur J Endocrinol. 2019 May 1;180(5):311-320. doi: 10.1530/EJE-19-0026.
2019
AOU San Luigi di Orbassano
Haak H; Baudin E; Sigala S; Mazziotti G; Cartry J; Grisanti S; Feelders RA; Bertherat J; Sukkari MA; Ettaieb H; Laganà M; Libè R; Berruti A; Habra MA; Terzolo M;
In vitro antitumor activity of progesterone in human adrenocortical carcinoma. in Endocrine / Endocrine. 2019 Mar;63(3):592-601. doi: 10.1007/s12020-018-1795-x. Epub 2018 Oct 26.
2019
AOU San Luigi di Orbassano
Memo M; Facchetti F; Missale C; Terzolo M; Bosisio D; Salvi V; Cosentini D; Claps M; Tiberio GAM; Grisanti S; Dalmiglio C; Bonini SA; Vezzoli S; Fisogni S; Fiorentini C; Rossini E; Fragni M; Berruti A; Sigala S;
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. in European journal of endocrinology / Eur J Endocrinol. 2019 Jun 1;180(6):387-396. doi: 10.1530/EJE-18-0923.
2019
AOU San Luigi di Orbassano
Berruti A; Reimondo G; Volante M; Veltri A; Porpiglia F; Berchialla P; Saba L; Pia A; Perotti P; Puglisi S; Basile V; Calabrese A; Terzolo M;
Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents. in Endocrine / Endocrine. 2019 Jun;64(3):724-726. doi: 10.1007/s12020-019-01947-4. Epub 2019 May 7.
2019
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
Berruti A; Vittorio Scagliotti G; Sigala S; Buttigliero C; Bedussi F; Dalla Volta A; Pia A; Ferrari L; Tucci M; Roca E;
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures(?). in Molecular and cellular endocrinology / Mol Cell Endocrinol. 2019 Dec 1;498:110585. doi: 10.1016/j.mce.2019.110585. Epub 2019 Sep 16.
2019
AOU San Luigi di Orbassano
Berruti A; Terzolo M; Memo M; Grisanti S; Tiberio GAM; Hantel C; Bosisio D; Vezzoli S; Poliani PL; Salvi V; Cosentini D; Abate A; Palma Lopez LP; Rossini E; Fragni M; Sigala S;
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients. in European journal of endocrinology / Eur J Endocrinol. 2019 Dec;181(6):681-689. doi: 10.1530/EJE-19-0570.
2019
AOU San Luigi di Orbassano
Volante M; Russo A; Sigala S; Incorvaia L; Luppi G; Dalla Volta A; Ferrari VD; Musso E; Laganà M; Perotti P; Spallanzani A; Cerri S; Rapa I; Basile V; Grisanti S; Badalamenti G; Cosentini D; Terzolo M; Berruti A;
Survival and Complication Rates of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma Treated Exclusively With Targeted Therapy: A Combined Population-based Analysis. in Anticancer research / Anticancer Res. 2019 Aug;39(8):4357-4361. doi: 10.21873/anticanres.13604.
2019
AOU San Luigi di Orbassano
ASL Città di Torino
Berruti A; Saad F; Briganti A; Simeone C; Shariat SF; Tian Z; Rosiello G; Knipper S; Pecoraro A; Palumbo C; Antonelli A; Karakiewicz PI;
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. in European journal of endocrinology / Eur J Endocrinol. 2018 Oct 1;179(4):G1-G46. doi: 10.1530/EJE-18-0608.
2018
AOU San Luigi di Orbassano
Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M;
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options. in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2018 Nov;18(11):1125-1133. doi: 10.1080/14737140.2018.1510325. Epub 2018
2018
AOU San Luigi di Orbassano
Puglisi S; Perotti P; Cosentini D; Roca E; Basile V; Berruti A; Terzolo M;
Palbociclib inhibits proliferation of human adrenocortical tumor cells. in Endocrine / Endocrine. 2018 Jan;59(1):213-217. doi: 10.1007/s12020-017-1270-0. Epub 2017 Mar 6.
2018
AOU San Luigi di Orbassano
Fiorentini C; Fragni M; Tiberio GAM; Galli D; Roca E; Salvi V; Bosisio D; Missale C; Terzolo M; Memo M; Berruti A; Sigala S;
The Circadian Rhythm of Breakthrough Pain Episodes in Terminally-ill Cancer Patients. in Cancers / Cancers (Basel). 2018 Dec 24;11(1):18. doi: 10.3390/cancers11010018.
2018
AOU San Luigi di Orbassano
Campagna S; Sperlinga R; Milo A; Sannuto S; Acquafredda F; Saini A; Gonella S; Berruti A; Scagliotti GV; Tampellini M;
Immunotherapy failure in adrenocortical cancer: where next? in Endocrine connections / Endocr Connect. 2018 Dec;7(12):E5-E8. doi: 10.1530/EC-18-0398.
2018
AOU San Luigi di Orbassano
Cosentini D; Grisanti S; Dalla Volta A; Laganà M; Fiorentini C; Perotti P; Sigala S; Berruti A;
Detailed genomic characterization identifies high heterogeneity and histotype-specific genomic profiles in adrenocortical carcinomas. in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc / Mod Pathol. 2018 Aug;31(8):1257-1269. doi: 10.1038/s41379-018-0042-6. Epub 2018 Mar 26.
2018
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Berruti A; Terzolo M; Scagliotti G; Germano A; Votta A; Rapa I; Izzo S; Giorcelli J; Duregon E; Volante M; Vatrano S; Papotti AM;
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells. in PloS one / PLoS One. 2018 May 7;13(5):e0196931. doi: 10.1371/journal.pone.0196931. eCollection 2018.
2018
AOU San Luigi di Orbassano
Germano A; Saba L; De Francia S; Rapa I; Perotti P; Berruti A; Volante M; Terzolo M;
Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2017 Nov;69(11):1524-1530. doi: 10.1111/jphp.12798. Epub 2017 Aug 15.
2017
AOU San Luigi di Orbassano
ASL Città di Torino
Tampellini M; Di Carlo F; Berruti A; Terzolo M; Daffara FC; Ferrero A; De Martino F; Piccione FM; Pirro E; Carrella S; Allegra S; De Francia S; Cusato J; D'Avolio A;
Topoisomerase 2? and thymidylate synthase expression in adrenocortical cancer. in Endocrine-related cancer / Endocr Relat Cancer. 2017 Jul;24(7):319-327. doi: 10.1530/ERC-17-0095. Epub 2017 Apr 21.
2017
AOU San Luigi di Orbassano
Roca E; Berruti A; Sbiera S; Rapa I; Oneda E; Sperone P; Ronchi CL; Ferrari L; Grisanti S; Germano A; Zaggia B; Scagliotti GV; Fassnacht M; Volante M; Terzolo M; Papotti M;
Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial. in The Lancet. Oncology / Lancet Oncol. 2017 Dec;18(12):1652-1664. doi: 10.1016/S1470-2045(17)30681-2. Epub 2017 Oct 23.
2017
AOU San Luigi di Orbassano
Ferolla P; Brizzi MP; Meyer T; Mansoor W; Mazieres J; Do Cao C; Léna H; Berruti A; Damiano V; Buikhuisen W; Grønbæk H; Lombard-Bohas C; Grohé C; Minotti V; Tiseo M; De Castro J; Reed N; Gislimberti G; Singh N; Stankovic M; Öberg K; Baudin E;
An exploratory analysis of the association between levels of hormones implied in steroid biosynthesis and activity of abiraterone in patients with metastatic castration-resistant prostate cancer. in Minerva urologica e nefrologica = The Italian journal of urology and nephrology / Minerva Urol Nefrol. 2017 Aug;69(4):349-358. doi: 10.23736/S0393-2249.16.02746-6. Epub 2016 Dec 22.
2017
AOU San Luigi di Orbassano
Bertaglia V; Tucci M; Vignani F; Buttigliero C; Aroasio E; Berruti A; Scagliotti GV; DI Maio M;
Management of patients with castration-resistant prostate cancer (CRPC): results of an Italian survey using the delphi method. in Tumori / Tumori. 2016 Oct 13;102(5):514-520. doi: 10.5301/tj.5000389. Epub 2015 Jun 30.
2016
AOU San Luigi di Orbassano
Terrone C; Berruti A; Papotti M; Vavassori V; Sciarra A;
Androgen deprivation modulates gene expression profile along prostate cancer progression. in Human pathology / Hum Pathol. 2016 Oct;56:81-8. doi: 10.1016/j.humpath.2016.06.004. Epub 2016 Jun 21.
2016
AOU San Luigi di Orbassano
Volante M; Tota D; Giorcelli J; Bollito E; Napoli F; Vatrano S; Buttigliero C; Molinaro L; Gontero P; Porpiglia F; Tucci M; Papotti M; Berruti A; Rapa I;
Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer. in Future oncology (London, England) / Future Oncol. 2016 Feb;12(4):493-502. doi: 10.2217/fon.15.302. Epub 2016 Jan 18.
2016
AOU San Luigi di Orbassano
ASL Torino 5
Santini D; Messina C; Perin A; Lodde M; Fratino L; Berruti A; Mucciarini C; Nicodemo M; Bonetti A; Alesini D; Zucali PA; Vicario G; Massari F; Lo Re G; Donini M; Bortolus R; Spizzo G; D'Angelo A; Zagonel V; Procopio G; Mattioli R; Mansueto G; Facchini G; Aieta M; Scognamiglio F; Ortega C; Di Lorenzo G; Caffo O; De Giorgi U; et alii...
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. in The Journal of clinical endocrinology and metabolism / J Clin Endocrinol Metab. 2016 Dec;101(12):4594-4602. doi: 10.1210/jc.2016-2414. Epub 2016 Sep 14.
2016
AOU San Luigi di Orbassano
Fiorentini C; Fragni M; Perego P; Vezzoli S; Bonini SA; Tortoreto M; Galli D; Claps M; Tiberio GA; Terzolo M; Missale C; Memo M; Procopio G; Zaffaroni N; Berruti A; Sigala S;
Does nephrectomy during radical adrenalectomy for stage II adrenocortical cancer affect patient outcome? in Journal of endocrinological investigation / J Endocrinol Invest. 2016 Apr;39(4):465-71. doi: 10.1007/s40618-015-0422-4. Epub 2015 Dec 22.
2016
AOU San Luigi di Orbassano
Porpiglia F; Fiori C; Daffara FC; Zaggia B; Ardito A; Scarpa RM; Papotti M; Berruti A; Scagliotti GV; Terzolo M;
The fat body mass increase after adjuvant androgen deprivation therapy is predictive of prostate cancer outcome. in Endocrine / Endocrine. 2015 Sep;50(1):223-30. doi: 10.1007/s12020-015-0525-x. Epub 2015 Jan 15.
2015
AOU San Luigi di Orbassano
Buttigliero C; Vana F; Bertaglia V; Vignani F; Fiori C; Osella G; Porpiglia F; Tucci M; Scagliotti GV; Berruti A;
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment. in Oncotarget / Oncotarget. 2015 May 20;6(14):12520-8. doi: 10.18632/oncotarget.3724.
2015
AOU San Luigi di Orbassano
Iuliani M; Pantano F; Buttigliero C; Fioramonti M; Bertaglia V; Vincenzi B; Zoccoli A; Ribelli G; Tucci M; Vignani F; Berruti A; Scagliotti GV; Tonini G; Santini D;
The prognostic role of baseline CEA and CA 19-9 values and their time-dependent variations in advanced colorectal cancer patients submitted to first-line therapy. in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine / Tumour Biol. 2015 Mar;36(3):1519-27. doi: 10.1007/s13277-014-2693-3. Epub 2014 Nov 6.
2015
AOU San Luigi di Orbassano
ASL Città di Torino
Tampellini M; Ottone A; Alabiso I; Baratelli C; Forti L; Berruti A; Aroasio E; Scagliotti GV;
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization. in Molecular and cellular endocrinology / Mol Cell Endocrinol. 2015 Feb 5;401:105-10. doi: 10.1016/j.mce.2014.11.027. Epub 2014 Dec 9.
2015
AOU San Luigi di Orbassano
Germano A; Rapa I; Volante M; De Francia S; Migliore C; Berruti A; Papotti M; Terzolo M;
Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation cases. in Human pathology / Hum Pathol. 2015 Dec;46(12):1799-807. doi: 10.1016/j.humpath.2015.08.012. Epub 2015 Sep 11.
2015
AOU San Luigi di Orbassano
Duregon E; Volante M; Bollito E; Goia M; Buttigliero C; Zaggia B; Berruti A; Scagliotti GV; Papotti M;
Alberta Breakthrough Pain Assessment Tool: A validation multicentre study in cancer patients with breakthrough pain. in European journal of pain (London, England) / Eur J Pain. 2015 Aug;19(7):881-8. doi: 10.1002/ejp.612. Epub 2014 Nov 5.
2015
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Sperlinga R; Campagna S; Berruti A; Laciura P; Ginosa I; Paoletti S; Giuliano PL; Tucci M; Rosato R; Scagliotti GV; Saini A;
Expression analysis of genes involved in DNA repair or synthesis in mixed neuroendocrine/nonneuroendocrine carcinomas. in Neuroendocrinology / Neuroendocrinology. 2015;101(2):151-60. doi: 10.1159/000375449. Epub 2015 Jan 29.
2015
AOU San Luigi di Orbassano
Volante M; Monica V; Birocco N; Brizzi MP; Busso S; Daniele L; La Rosa S; Righi L; Sapino A; Berruti A; Scagliotti GV; Papotti M;
Association between levels of hormones implied in steroid biosynthesis pathway and activity of abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): An exploratory analysis in Journal of Clinical Oncology
2015
AOU San Luigi di Orbassano
Tucci M; Vignani F; Bertaglia V; Buttigliero C; Berruti A; Scagliotti GV; Di Maio M;
Real-world study of everolimus in advanced progressive neuroendocrine tumors. in The oncologist / Oncologist. 2014 Sep;19(9):966-74. doi: 10.1634/theoncologist.2014-0037. Epub 2014 Aug 12.
2014
AOU San Luigi di Orbassano
AO Cuneo
Delle Fave G; Falconi M; Colao A; Berruti A; Appetecchia M; Cartenì G; Campana D; Cassano A; Ambrosio MR; Fontana A; Pusceddu S; Spada F; Funaioli C; Antonuzzo L; Chiara S; Merlano M; Cascinu S; Pastorelli D; Faggiano A; Nobili E; Zaniboni A; Brizzi MP; Nuzzo C; Riccardi F; Tomassetti P; Lugli F; Zatelli MC; Luppi G; de Braud F; et alii...
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines. in Molecular and cellular endocrinology / Mol Cell Endocrinol. 2014 Jan 25;382(1):1-7. doi: 10.1016/j.mce.2013.08.023. Epub 2013 Sep 7.
2014
AOU San Luigi di Orbassano
Germano A; Rapa I; Volante M; Lo Buono N; Carturan S; Berruti A; Terzolo M; Papotti M;
Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studies. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2014 Dec 1;32(34):3883-91. doi: 10.1200/JCO.2014.55.2836. Epub 2014 Oct 27.
2014
AOU San Luigi di Orbassano
Berruti A; Amoroso V; Gallo F; Bertaglia V; Simoncini E; Pedersini R; Ferrari L; Bottini A; Bruzzi P; Sormani MP;
Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. in European urology / Eur Urol. 2014 Apr;65(4):832-8. doi: 10.1016/j.eururo.2013.11.006. Epub 2013 Nov 14.
2014
AOU San Luigi di Orbassano
Berruti A; Fassnacht M; Haak H; Else T; Baudin E; Sperone P; Kroiss M; Kerkhofs T; Williams AR; Ardito A; Leboulleux S; Volante M; Deutschbein T; Feelders R; Ronchi C; Grisanti S; Gelderblom H; Porpiglia F; Papotti M; Hammer GD; Allolio B; Terzolo M;
Intermittent everolimus administration for malignant insulinoma. in Endocrinology, diabetes & metabolism case reports / Endocrinol Diabetes Metab Case Rep. 2014;2014:140047. doi: 10.1530/EDM-14-0047. Epub 2014 Sep 1.
2014
AOU San Luigi di Orbassano
Baratelli C; Brizzi MP; Tampellini M; Scagliotti GV; Priola A; Terzolo M; Pia A; Berruti A;
The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases. in The American journal of surgical pathology / Am J Surg Pathol. 2013 Sep;37(9):1433-40. doi: 10.1097/PAS.0b013e31828d387b.
2013
AOU San Luigi di Orbassano
Duregon E; Fassina A; Volante M; Nesi G; Santi R; Gatti G; Cappellesso R; Dalino Ciaramella P; Ventura L; Gambacorta M; Dei Tos AP; Loli P; Mannelli M; Mantero F; Berruti A; Terzolo M; Papotti M;
Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection. in European journal of endocrinology / Eur J Endocrinol. 2013 Jul 29;169(3):263-70. doi: 10.1530/EJE-13-0242. Print 2013 Sep.
2013
AOU San Luigi di Orbassano
Terzolo M; Baudin AE; Ardito A; Kroiss M; Leboulleux S; Daffara F; Perotti P; Feelders RA; deVries JH; Zaggia B; De Francia S; Volante M; Haak HR; Allolio B; Al Ghuzlan A; Fassnacht M; Berruti A;
Metronomic chemotherapy may be active in heavily pre-treated patients with metastatic adreno-cortical carcinoma. in Journal of endocrinological investigation / J Endocrinol Invest. 2013 Mar;36(3):148-52. doi: 10.3275/8334. Epub 2012 Apr 5.
2013
AOU San Luigi di Orbassano
Ferrero A; Sperone P; Ardito A; Rossi G; Del Buono S; Priola AM; Bracarda S; Taberna E; Terzolo M; Berruti A;
Restless legs syndrome as a cause of sleep disturbances in cancer patients receiving chemotherapy. in Journal of pain and symptom management / J Pain Symptom Manage. 2013 Jul;46(1):56-64. doi: 10.1016/j.jpainsymman.2012.06.018. Epub 2012 Oct 3
2013
AOU San Luigi di Orbassano
Saini A; Berruti A; Ferini-Strambi L; Castronovo V; Rametti E; Giuliano PL; Ramassotto B; Picci RL; Negro M; Campagna S; Furlan PM; Ostacoli L;
Circadian variation of breakthrough pain in cancer patients. in European journal of pain (London, England) / Eur J Pain. 2013 Feb;17(2):264-70. doi: 10.1002/j.1532-2149.2012.00184.x. Epub 2012 Jun 19.
2013
AOU San Luigi di Orbassano
ASL Cuneo 1
Saini A; Tucci M; Tampellini M; Maina D; Bouraouia K; Giuliano PL; Termine A; Castellano M; Campagna S; Laciura P; Berruti A;
Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone. in Cancer treatment reviews / Cancer Treat Rev. 2013 Dec;39(8):966-73. doi: 10.1016/j.ctrv.2013.03.003. Epub 2013 Apr 10.
2013
AOU San Luigi di Orbassano
Pia A; Vignani F; Attard G; Tucci M; Bironzo P; Scagliotti G; Arlt W; Terzolo M; Berruti A;
Human ASH-1 promotes neuroendocrine differentiation in androgen deprivation conditions and interferes with androgen responsiveness in prostate cancer cells. in The Prostate / Prostate. 2013 Aug;73(11):1241-9. doi: 10.1002/pros.22679. Epub 2013 May 8.
2013
AOU San Luigi di Orbassano
Rapa I; Volante M; Migliore C; Farsetti A; Berruti A; Vittorio Scagliotti G; Giordano S; Papotti M;
Tumor staging but not grading is associated with adverse clinical outcome in neuroendocrine tumors of the appendix: a retrospective clinical pathologic analysis of 138 cases. in The American journal of surgical pathology / Am J Surg Pathol. 2013 Apr;37(4):606-12. doi: 10.1097/PAS.0b013e318275d1d7.
2013
AOU San Luigi di Orbassano
ASL Città di Torino
ASL Cuneo 2
Volante M; Daniele L; Asioli S; Cassoni P; Comino A; Coverlizza S; De Giuli P; Fava C; Manini C; Berruti A; Papotti M;
Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey. in PloS one / PLoS One. 2013 Dec 30;8(12):e83026. doi: 10.1371/journal.pone.0083026. eCollection 2013.
2013
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Sabbatini R; Maiello E; Adamo V; Tanca FM; Fedeli SL; Badalamenti G; Russo A; Collovà E; Satolli MA; Silvestris N; Santoni M; Virzì V; Lanzetta G; Carteni G; Ottaviani D; Ortega C; Vincenzi B; Berardi R; Berruti A; Fontana A; Mazzara C; Barni S; Porta C; Ibrahim T; Procopio G; Santini D; Felici A; Cinieri S; Tonini G; et alii...
Pathological complete response after primary chemotherapy as a surrogate end point of treatment efficacy in breast cancer patients: A trial-based meta-analysis in Cancer Research
2013
AOU San Luigi di Orbassano
Amoroso V; Berruti A; Gallo F; Bertaglia V; Paloja E; Simoncini EL; Generali D; Bottini A; Bruzzi P; Sormani MP;
Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2012 Oct;23 Suppl 7:vii131-8. doi: 10.1093/annonc/mds231.
2012
AOU San Luigi di Orbassano
Berruti A; Baudin E; Gelderblom H; Haak HR; Porpiglia F; Fassnacht M; Pentheroudakis G;
Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma. in European journal of endocrinology / Eur J Endocrinol. 2012 Mar;166(3):451-8. doi: 10.1530/EJE-11-0918. Epub 2011 Dec 21.
2012
AOU San Luigi di Orbassano
Berruti A; Sperone P; Ferrero A; Germano A; Ardito A; Priola AM; De Francia S; Volante M; Daffara F; Generali D; Leboulleux S; Perotti P; Baudin E; Papotti M; Terzolo M;
Ribonucleotide reductase large subunit (RRM1) gene expression may predict efficacy of adjuvant mitotane in adrenocortical cancer. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2012 Jun 15;18(12):3452-61. doi: 10.1158/1078-0432.CCR-11-2692. Epub 2012 Apr 30.
2012
AOU San Luigi di Orbassano
Volante M; Terzolo M; Fassnacht M; Rapa I; Germano A; Sbiera S; Daffara F; Sperone P; Scagliotti G; Allolio B; Papotti M; Berruti A;
Management of adjuvant mitotane therapy following resection of adrenal cancer. in Endocrine / Endocrine. 2012 Dec;42(3):521-5. doi: 10.1007/s12020-012-9719-7. Epub 2012 Jun 17.
2012
AOU San Luigi di Orbassano
Terzolo M; Ardito A; Zaggia B; Laino F; Germano A; De Francia S; Daffara F; Berruti A;
The role of lung metastasis resection in improving outcome of colorectal cancer patients: results from a large retrospective study. in The oncologist / Oncologist. 2012;17(11):1430-8. doi: 10.1634/theoncologist.2012-0142. Epub 2012 Sep 6.
2012
AOU San Luigi di Orbassano
AO Ordine Mauriziano
Tampellini M; Ottone A; Bellini E; Alabiso I; Baratelli C; Bitossi R; Brizzi MP; Ferrero A; Sperti E; Leone F; Miraglia S; Forti L; Bertona E; Ardissone F; Berruti A; Alabiso O; Aglietta M; Scagliotti GV;
Prognostic role of serum parathyroid hormone levels in advanced prostate cancer patients undergoing zoledronic acid administration. in The oncologist / Oncologist. 2012;17(5):645-52. doi: 10.1634/theoncologist.2011-0448. Epub 2012 Apr 20.
2012
AOU San Luigi di Orbassano
Berruti A; Cook R; Saad F; Buttigliero C; Lipton A; Tampellini M; Lee KA; Coleman RE; Smith MR;
2012
AOU San Luigi di Orbassano
Allevi G; Strina C; Andreis D; Zanoni V; Bazzola L; Bonardi S; Foroni C; Milani M; Cappelletti MR; Generali D; Berruti A; Bottini A;
Natural history of malignant bone disease in renal cancer: Final results of an Italian bone metastases survey in Journal of Clinical Oncology
2012
AOU San Luigi di Orbassano
Santini D; Procopio G; Porta C; Mazzara C; Barni S; Fontana A; Berruti A; Berardi R; Vincenzi B; Ortega C; Ibrahim T; Ottaviani D; Carteni G; Lanzetta G; Virzì V; Silvestris N; Tanca FM; Adamo V; Tonini G; Bracarda S;
Prevalence of complementary/alternative medicines (CAMs) in a cancer population in northern Italy receiving antineoplastic treatments and relationship with quality of life and psychometric features. in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation / Qual Life Res. 2011 Jun;20(5):683-90. doi: 10.1007/s11136-010-9795-1. Epub 2010 Nov 16.
2011
AOU San Luigi di Orbassano
Saini A; Berruti A; Capogna S; Negro M; Sguazzotti E; Picci RL; Campagna S; Dongiovanni V; Dogliotti L; Furlan PM; Ostacoli L;
Oncocytic adrenocortical tumors: diagnostic algorithm and mitochondrial DNA profile in 27 cases. in The American journal of surgical pathology / Am J Surg Pathol. 2011 Dec;35(12):1882-93. doi: 10.1097/PAS.0b013e31822da401.
2011
AOU San Luigi di Orbassano
Duregon E; Volante M; Cappia S; Cuccurullo A; Bisceglia M; Wong DD; Spagnolo DV; Szpak-Ulczok S; Bollito E; Daffara F; Berruti A; Terzolo M; Papotti M;
The pathological diagnosis of neuroendocrine tumors: common questions and tentative answers. in Virchows Archiv : an international journal of pathology / Virchows Arch. 2011 Apr;458(4):393-402. doi: 10.1007/s00428-011-1060-7. Epub 2011 Feb 23.
2011
AOU San Luigi di Orbassano
Volante M; Righi L; Berruti A; Rindi G; Papotti M;
Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patients. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2011 Apr;47(6):814-8. doi: 10.1016/j.ejca.2010.12.026. Epub 2011 Feb 18.
2011
AOU San Luigi di Orbassano
Guglielmelli T; Bringhen S; Rrodhe S; Gay F; Cavallo F; Berruti A; Montefusco V; Piro E; Benevolo G; Petrucci MT; Caravita T; Offidani M; Corradini P; Boccadoro M; Saglio G; Palumbo A;
Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (FGF23)-independent mechanism. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2011 Apr;22(4):988-990. doi: 10.1093/annonc/mdr010. Epub 2011 Feb 14.
2011
AOU San Luigi di Orbassano
Bellini E; Pia A; Brizzi MP; Tampellini M; Torta M; Terzolo M; Dogliotti L; Berruti A;
International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010). in Journal of the National Cancer Institute. Monographs / J Natl Cancer Inst Monogr. 2011;2011(43):147-51. doi: 10.1093/jncimonographs/lgr037.
2011
AOU San Luigi di Orbassano
Berruti A; Generali D; Kaufmann M; Puztai L; Curigliano G; Aglietta M; Gianni L; Miller WR; Untch M; Sotiriou C; Daidone M; Conte P; Kennedy D; Damia G; Petronini P; Di Cosimo S; Bruzzi P; Dowsett M; Desmedt C; Mansel RE; Olivetti L; Tondini C; Sapino A; Fenaroli P; Tortora G; Thorne H; Bertolini F; Ferrozzi F; Danova M; et alii...
Intermediate endpoints of primary systemic therapy in breast cancer patients. in Journal of the National Cancer Institute. Monographs / J Natl Cancer Inst Monogr. 2011;2011(43):142-6. doi: 10.1093/jncimonographs/lgr036.
2011
AOU San Luigi di Orbassano
Berruti A; Generali D; Bertaglia V; Brizzi MP; Mele T; Dogliotti L; Bruzzi P; Bottini A;
Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review. in The oncologist / Oncologist. 2011;16(9):1215-27. doi: 10.1634/theoncologist.2011-0098. Epub 2011 Aug 11.
2011
AOU San Luigi di Orbassano
Buttigliero C; Monagheddu C; Petroni P; Saini A; Dogliotti L; Ciccone G; Berruti A;
Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients in Oncology Reports
2011
AOU San Luigi di Orbassano
AOU Alessandria
Santini D; Vincenzi B; Adamo V; Addeo R; Fusco V; Russo A; Montemurro F; Roato I; Redana S; Lanzetta G; Satolli MA; Berruti A; Leoni V; Galluzzo S; Antimi M; Ferraro G; Del Salvatore P; Valerio MR; Marra M; Caraglia M; Tonini G;
Sentinel lymph node mapping in breast cancer after primary chemotherapy in Cancer Research
2011
AOU San Luigi di Orbassano
Bonardi S; Andreis D; Allevi G; Aguggini S; Milani M; Generali D; Bersiga A; Brizzi MP; Dogliotti L; Berruti A; Bottini A;
Metronomic Therapy Concepts in the Management of Adrenocortical Carcinoma in Hormones and Cancer
2011
AOU San Luigi di Orbassano
Berruti A; Sperone P; Bellini E; Daffara F; Perotti P; Ardito A; Saini A; Terzolo M;
Molecular oncology and the neoadjuvant setting: The perfect blend for treatment personalization and clinical trial design in Journal of the National Cancer Institute - Monographs
2011
AOU San Luigi di Orbassano
Generali D; Berruti A; Foroni C; Bazzola L; Andreis D; Allevi G; Bersiga A; Dogliotti L; Fox SB; Harris AL; Bottini A;
Predictive immunohistochemical biomarkers in the context of neoadjuvant therapy for breast cancer in Journal of the National Cancer Institute - Monographs
2011
AOU San Luigi di Orbassano
Generali D; Symmans WF; Berruti A; Fox SB;
Expression pattern of receptor activator of NF?B (RANK) in a series of primary solid tumors and related bone metastases in Journal of Cellular Physiology
2011
AOU San Luigi di Orbassano
Santini D; Perrone G; Roato I; Godio L; Pantano F; Grasso D; Russo A; Vincenzi B; Fratto ME; Sabbatini R; Della Pepa C; Porta C; Del Conte A; Schiavon G; Berruti A; Tomasino RM; Papotti M; Papapietro N; Onetti Muda A; Denaro V; Tonini G;
The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1? and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen in Breast Cancer Research
2011
AOU San Luigi di Orbassano
Fox SB; Generali D; Berruti A; Brizzi MP; Campo L; Bonardi S; Bersiga A; Allevi G; Milani M; Aguggini S; Mele T; Dogliotti L; Bottini A; Harris AL;
Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients. in Breast cancer research and treatment / Breast Cancer Res Treat. 2010 Oct;123(3):795-804. doi: 10.1007/s10549-010-1063-0. Epub 2010 Aug 3.
2010
AOU San Luigi di Orbassano
Mele T; Generali D; Fox S; Brizzi MP; Bersiga A; Milani M; Allevi G; Bonardi S; Aguggini S; Volante M; Dogliotti L; Bottini A; Harris A; Berruti A;
Restless legs syndrome and its relationship with anxiety, depression, and quality of life in cancer patients undergoing chemotherapy. in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation / Qual Life Res. 2010 May;19(4):531-7. doi: 10.1007/s11136-010-9614-8. Epub 2010 Feb 27.
2010
AOU San Luigi di Orbassano
Ostacoli L; Saini A; Ferini-Strambi L; Castronovo V; Sguazzotti E; Picci RL; Toje M; Gorzegno G; Capogna S; Dongiovanni V; Dogliotti L; Furlan PM; Berruti A;
Diagnostic accuracy and complication rate of CT-guided fine needle aspiration biopsy of lung lesions: a study based on the experience of the cytopathologist. in Acta radiologica (Stockholm, Sweden : 1987) / Acta Radiol. 2010 Jun;51(5):527-33. doi: 10.3109/02841851003691979.
2010
AOU San Luigi di Orbassano
Priola AM; Priola SM; Cataldi A; Di Franco M; Pazè F; Marci V; Berruti A;
Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle. in Open access journal of urology / Open Access J Urol. 2010 Jul 23;2:109-24. doi: 10.2147/rru.s6573.
2010
AOU San Luigi di Orbassano
Berruti A; Vignani F; Russo L; Bertaglia V; Tullio M; Tucci M; Poggio M; Dogliotti L;
Stage I-II adrenocortical cancer: Open or Laparoscopic adrenalectomy in European Urology, Supplements
2010
AOU San Luigi di Orbassano
Porpialia F; Fiori C; Scarpa RM; Daffara F; Zaggia B; Bollito E; Berruti A; Terzolo M;
Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network. in BMC cancer / BMC Cancer. 2009 Nov 3;9:388. doi: 10.1186/1471-2407-9-388.
2009
AOU San Luigi di Orbassano
ASL Torino 4
AOU Città della Salute di Torino
Brizzi MP; Berruti A; Ferrero A; Milanesi E; Volante M; Castiglione F; Birocco N; Bombaci S; Perroni D; Ferretti B; Alabiso O; Ciuffreda L; Bertetto O; Papotti M; Dogliotti L;
Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease. in Prostate cancer and prostatic diseases / Prostate Cancer Prostatic Dis. 2009;12(1):94-9. doi: 10.1038/pcan.2008.10. Epub 2008 Mar 11.
2009
AOU San Luigi di Orbassano
Tucci M; Mosca A; Lamanna G; Porpiglia F; Terzolo M; Vana F; Cracco C; Russo L; Gorzegno G; Tampellini M; Torta M; Reimondo G; Poggio M; Scarpa RM; Angeli A; Dogliotti L; Berruti A;
Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients in Clinical Cancer Research
2009
AOU San Luigi di Orbassano
Generali D; Bates G; Berruti A; Brizzi MP; Campo L; Bonardi S; Bersiga A; Allevi G; Milani M; Aguggini S; Dogliotti L; Banham AH; Harris AL; Bottini A; Fox SB;
Gemcitabine and protracted 5-fluorouracil infusion as third-line chemotherapy in refractory colorectal cancer patients. in Anticancer research / Anticancer Res. 2008 Sep-Oct;28(5B):3055-60.
2008
AOU San Luigi di Orbassano
Bitossi R; Sculli CM; Tampellini M; Alabiso I; Brizzi MP; Ferrero A; Ottone A; Bellini E; Gorzegno G; Berruti A; Dogliotti L;
Emerging drugs for adrenocortical carcinoma. in Expert opinion on emerging drugs / Expert Opin Emerg Drugs. 2008 Sep;13(3):497-509. doi: 10.1517/14728214.13.3.497.
2008
AOU San Luigi di Orbassano
Berruti A; Ferrero A; Sperone P; Daffara F; Reimondo G; Papotti M; Dogliotti L; Angeli A; Terzolo M;
Presurgical systemic treatment of nonmetastatic breast cancer: facts and open questions. in The oncologist / Oncologist. 2008 Nov;13(11):1137-48. doi: 10.1634/theoncologist.2008-0162. Epub 2008 Nov 7.
2008
AOU San Luigi di Orbassano
ASL Torino 5
Berruti A; Brizzi MP; Generali D; Ardine M; Dogliotti L; Bruzzi P; Bottini A;
Pathological and molecular features of adrenocortical carcinoma: an update. in Journal of clinical pathology / J Clin Pathol. 2008 Jul;61(7):787-93. doi: 10.1136/jcp.2007.050625. Epub 2008 Apr 22.
2008
AOU San Luigi di Orbassano
Volante M; Buttigliero C; Greco E; Berruti A; Papotti M;
Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly. in Endocrine-related cancer / Endocr Relat Cancer. 2008 Dec;15(4):1043-53. doi: 10.1677/ERC-08-0103. Epub 2008 Sep 29.
2008
AOU San Luigi di Orbassano
Daffara F; De Francia S; Reimondo G; Zaggia B; Aroasio E; Porpiglia F; Volante M; Termine A; Di Carlo F; Dogliotti L; Angeli A; Berruti A; Terzolo M;
Mammaprint®: Predictive tool of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients in Annals of Oncology
2008
AOU San Luigi di Orbassano
Generali DG; Bazzola L; Foroni C; Berruti A; Dogliotti L; Fox SB; Bottini A;
Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases in British Journal of Cancer
2008
AOU San Luigi di Orbassano
Generali D; Dovio A; Tampellini M; Tucci M; Tedoldi S; Torta M; Bonardi S; Allevi G; Aguggini S; Milani M; Harris AL; Bottini A; Dogliotti L; Angeli A; Berruti A;
Down-regulation of phosphatidylinositol 3?-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancer in Clinical Cancer Research
2008
AOU San Luigi di Orbassano
Generali D; Fox SB; Brizzi MP; Allevi G; Bonardi S; Aguggini S; Milani M; Bersiga A; Campo L; Dionisio R; Vergoni F; Giardini R; Dogliotti L; Bottini A; Harris AL; Berruti A;
Development and validation of a patient-physician relationship index in the advanced cancer setting. in Tumori / Tumori. 2007 Sep-Oct;93(5):485-90.
2007
AOU San Luigi di Orbassano
Ostacoli L; Costantini M; Beccaro M; Dellai M; Gorzegno G; Picci RL; Sguazzotti E; Berruti A; Torta R; Furlan PM;
Chromogranin A expression in patients with hormone naïve prostate cancer predicts the development of hormone refractory disease. in The Journal of urology / J Urol. 2007 Sep;178(3 Pt 1):838-43; quiz 1129. doi: 10.1016/j.juro.2007.05.018. Epub 2007 Jul 16.
2007
AOU San Luigi di Orbassano
Berruti A; Mosca A; Porpiglia F; Bollito E; Tucci M; Vana F; Cracco C; Torta M; Russo L; Cappia S; Saini A; Angeli A; Papotti M; Scarpa RM; Dogliotti L;
Thrombotic thrombocytopenic purpura in advanced prostate cancer: case report and published work review. in International journal of urology : official journal of the Japanese Urological Association / Int J Urol. 2007 Feb;14(2):150-2. doi: 10.1111/j.1442-2042.2006.01644.x.
2007
AOU San Luigi di Orbassano
Caramello V; Dovio A; Caraci P; Berruti A; Angeli A;
Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer in Clinical Cancer Research
2007
AOU San Luigi di Orbassano
Generali D; Fox SB; Berruti A; Moore JW; Brizzi MP; Patel N; Allevi G; Bonardi S; Aguggini S; Bersiga A; Campo L; Dogliotti L; Bottini A; Harris AL;
A new simple HPLC method for measuring mitotane and its two principal metabolites Tests in animals and mitotane-treated patients. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Jun 6;837(1-2):69-75. doi: 10.1016/j.jchromb.200
2006
AOU San Luigi di Orbassano
De Francia S; Pirro E; Zappia F; De Martino F; Sprio AE; Daffara F; Terzolo M; Berruti A; Di Carlo F; Ghezzo F;
Long-term disease free survival in a patient with metastatic adreno-cortical carcinoma after complete pathological response to chemotherapy plus mitotane. in Journal of endocrinological investigation / J Endocrinol Invest. 2006 Jun;29(6):560-2. doi: 10.1007/BF03344148.
2006
AOU San Luigi di Orbassano
Sperone P; Berruti A; Gorzegno G; Paccotti P; Terzolo M; Porpiglia F; Angeli A; Dogliotti L;
The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients. in British journal of cancer / Br J Cancer. 2006 Jul 3;95(1):13-20. doi: 10.1038/sj.bjc.6603204. Epub 2006 Jun 13.
2006
AOU San Luigi di Orbassano
Tampellini M; Saini A; Alabiso I; Bitossi R; Brizzi MP; Sculli CM; Berruti A; Gorzegno G; Magnino A; Sperti E; Miraglia S; Forti L; Alabiso O; Aglietta M; Harris A; Dogliotti L;
Recall inflammatory skin reaction after use of pegylated liposomal doxorubicin in site of previous drug extravasation. in The Lancet. Oncology / Lancet Oncol. 2006 Feb;7(2):186-7. doi: 10.1016/S1470-2045(06)70582-4.
2006
AOU San Luigi di Orbassano
Saini A; Berruti A; Sperone P; Bitossi R; Tampellini M; Dogliotti L; Gorzegno G;
Reassessing the current TNM lymph node staging for renal cell carcinoma. in European urology / Eur Urol. 2006 Feb;49(2):324-31. doi: 10.1016/j.eururo.2005.11.014. Epub 2005 Dec 20.
2006
AOU San Luigi di Orbassano
Terrone C; Cracco C; Porpiglia F; Bollito E; Scoffone C; Poggio M; Berruti A; Ragni F; Cossu M; Scarpa RM; Rossetti SR;
Matrix metalloproteinase type 2 expression in malignant adrenocortical tumors: Diagnostic and prognostic significance in a series of 50 adrenocortical carcinomas. in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc / Mod Pathol. 2006 Dec;19(12):1563-9. doi: 10.1038/modpathol.3800683. Epub 2006 Sep 15.
2006
AOU San Luigi di Orbassano
Volante M; Sperone P; Bollito E; Frangipane E; Rosas R; Daffara F; Terzolo M; Berruti A; Papotti M;
Stage IB malignant thymoma in a Lynch syndrome patient with multiple cancers: response to incidental administration of oxaliplatin and 5-fluorouracil. in Journal of chemotherapy (Florence, Italy) / J Chemother. 2006 Aug;18(4):433-6. doi: 10.1179/joc.2006.18.4.433.
2006
AOU San Luigi di Orbassano
Tampellini M; Alabiso I; Sculli CM; Barberis M; Giachino D; Berruti A; Dogliotti L;
Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients. in Breast cancer research and treatment / Breast Cancer Res Treat. 2006 Aug;98(3):241-8. doi: 10.1007/s10549-005-9155-y. Epub 2006 May 3.
2006
AOU San Luigi di Orbassano
Tampellini M; Berruti A; Bitossi R; Gorzegno G; Alabiso I; Bottini A; Farris A; Donadio M; Sarobba MG; Manzin E; Durando A; Defabiani E; De Matteis A; Ardine M; Castiglione F; Danese S; Bertone E; Alabiso O; Massobrio M; Dogliotti L;
Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer in Endocrine-Related Cancer
2006
AOU San Luigi di Orbassano
Generali D; Fox SB; Berruti A; Brizzi MP; Campo L; Bonardi S; Wigfield SM; Bruzzi P; Bersiga A; Allevi G; Milani M; Aguggini S; Dogliotti L; Bottini A; Harris AL;
Hypoxia-inducible factor-1? expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer in Clinical Cancer Research
2006
AOU San Luigi di Orbassano
Generali D; Berruti A; Brizzi MP; Campo L; Bonardi S; Wigfield S; Bersiga A; Allevi G; Milani M; Aguggini S; Gandolfi V; Dogliotti L; Bottini A; Harris AL; Fox SB;
Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease. in British journal of cancer / Br J Cancer. 2005 Sep 19;93(6):633-8. doi: 10.1038/sj.bjc.6602767.
2005
AOU San Luigi di Orbassano
Berruti A; Tucci M; Mosca A; Tarabuzzi R; Gorzegno G; Terrone C; Vana F; Lamanna G; Tampellini M; Porpiglia F; Angeli A; Scarpa RM; Dogliotti L;
Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial. in Endocrine-related cancer / Endocr Relat Cancer. 2005 Sep;12(3):657-66. doi: 10.1677/erc.1.01025.
2005
AOU San Luigi di Orbassano
Berruti A; Terzolo M; Sperone P; Pia A; Della Casa S; Gross DJ; Carnaghi C; Casali P; Porpiglia F; Mantero F; Reimondo G; Angeli A; Dogliotti L;
Feasibility of 21-day continuous infusion of epirubicin in hormone-refractory prostate cancer patients. in Anticancer research / Anticancer Res. 2005 Nov-Dec;25(6C):4475-9.
2005
AOU San Luigi di Orbassano
Berruti A; Mosca A; Bitossi R; Gorzegno G; Guercio S; Poggio M; Tampellini M; Porpiglia F; Ostellino O; Scarpa RM; Dogliotti L;
Cytotoxic and antiproliferative activity of the single agent epirubicin versus epirubicin plus tamoxifen as primary chemotherapy in human breast cancer: a single-institution phase III trial. in Endocrine-related cancer / Endocr Relat Cancer. 2005 Jun;12(2):383-92. doi: 10.1677/erc.1.00945.
2005
AOU San Luigi di Orbassano
Bottini A; Berruti A; Brizzi MP; Bersiga A; Generali D; Allevi G; Aguggini S; Bolsi G; Bonardi S; Tondelli B; Vana F; Tampellini M; Alquati P; Dogliotti L;
Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: a phase II study with a 5-year follow-up. in Urologic oncology / Urol Oncol. 2005 Jan-Feb;23(1):1-7. doi: 10.1016/j.urolonc.2004.06.003.
2005
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Berruti A; Fara E; Tucci M; Tarabuzzi R; Mosca A; Terrone C; Gorzegno G; Fasolis G; Tampellini M; Porpiglia F; De Stefanis M; Fontana D; Bertetto O; Dogliotti L;
Combination regimen of epirubicin, vinorelbine and 5-fluorouracil continuous infusion as first-line chemotherapy in anthracycline-naive metastatic breast cancer patients. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2005 Jan;41(2):249-55. doi: 10.1016/j.ejca.2004.07.003.
2005
AOU San Luigi di Orbassano
Berruti A; Bitossi R; Bottini A; Bonardi S; Donadio M; Nigro C; Bertetto O; Danese S; Bertone E; Sarobba MG; Farris A; Katsaros D; Castiglione F; Volpe T; Lattuada S; Mancarella S; Dogliotti L;
Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines. in British journal of cancer / Br J Cancer. 2005 Feb 28;92(4):634-8. doi: 10.1038/sj.bjc.6602335.
2005
AOU San Luigi di Orbassano
Berruti A; Bitossi R; Gorzegno G; Bottini A; Generali D; Milani M; Katsaros D; Rigault de la Longrais IA; Bellino R; Donadio M; Ardine M; Bertetto O; Danese S; Sarobba MG; Farris A; Lorusso V; Dogliotti L;
Sequential chemotherapy of cisplatin and vinorelbine followed by paclitaxel and gemcitabine in advanced non-small-cell lung cancer. A single institution phase II study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2005 Feb;47(2):269-75. doi: 10.1016/j.lungcan.2004.06.019.
2005
AOU Città della Salute di Torino
AOU San Luigi di Orbassano
Dongiovanni D; Fissore C; Berruti A; Buffoni L; Addeo A; Barone C; Polimeni MA; Ottaviani D; Bertetto O; Dongiovanni V;
The neuroendocrine phenotype in prostate cancer: basic and clinical aspects. in Journal of endocrinological investigation / J Endocrinol Invest. 2005;28(11 Suppl International):141-5.
2005
AOU San Luigi di Orbassano
Mosca A; Berruti A; Russo L; Torta M; Dogliotti L;
Somatostatin receptors: from basic science to clinical approach. Unlabeled somatostatin analogues-1: Prostate cancer. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2004 Feb;36 Suppl 1:S60-7. doi: 10.1016/j.dld.2003.11.021.
2004
AOU San Luigi di Orbassano
Mosca A; Dogliotti L; Berruti A; Lamberts SW; Hofland LJ;
Management of neuroendocrine differentiated breast carcinoma. in Breast (Edinburgh, Scotland) / Breast. 2004 Dec;13(6):527-9. doi: 10.1016/j.breast.2004.06.007.
2004
AOU San Luigi di Orbassano
Berruti A; Saini A; Leonardo E; Cappia S; Borasio P; Dogliotti L;
Metabolic effects of single-dose pamidronate administration in prostate cancer patients with bone metastases. in The International journal of biological markers / Int J Biol Markers. 2002 Oct-Dec;17(4):244-52. doi: 10.5301/jbm.2008.2194.
2002
AOU San Luigi di Orbassano
Berruti A; Dogliotti L; Tucci M; Tarabuzzi R; Guercio S; Torta M; Tampellini M; Dovio A; Poggio M; Scarpa RM; Angeli A;
Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: final results of a phase III study with a factorial design. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2002 Oct 15;20(20):4150-9. doi: 10.1200/JCO.2002.08.012.
2002
AOU San Luigi di Orbassano
Berruti A; Bitossi R; Gorzegno G; Bottini A; Alquati P; De Matteis A; Nuzzo F; Giardina G; Danese S; De Lena M; Lorusso V; Farris A; Sarobba MG; DeFabiani E; Bonazzi G; Castiglione F; Bumma C; Moro G; Bruzzi P; Dogliotti L;
Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy. in The Journal of urology / J Urol. 2002 Jun;167(6):2361-7; discussion 2367.
2002
AOU San Luigi di Orbassano
Berruti A; Dogliotti L; Terrone C; Cerutti S; Isaia G; Tarabuzzi R; Reimondo G; Mari M; Ardissone P; De Luca S; Fasolis G; Fontana D; Rossetti SR; Angeli A;
Background to and management of treatment-related bone loss in prostate cancer. in Drugs & aging / Drugs Aging. 2002;19(12):899-910. doi: 10.2165/00002512-200219120-00002.
2002
AOU San Luigi di Orbassano
Berruti A; Tucci M; Terrone C; Gorzegno G; Scarpa RM; Angeli A; Dogliotti L;
Independent factors predict supranormal CA 15-3 serum levels in advanced breast cancer patients at first disease relapse. in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine / Tumour Biol. 2001 Nov-Dec;22(6):367-73. doi: 10.1159/000050639.
2001
AOU San Luigi di Orbassano
Tampellini M; Berruti A; Gorzegno G; Bitossi R; Bottini A; Durando A; De Matteis A; Farris A; Donadio M; De Fabiani E; Manzin E; Arese P; Sarobba MG; Castiglione F; Moro G; Bonazzi G; Nuzzo F; Massobrio M; Dogliotti L;
Effects of the somatostatin analog lanreotide on the circulating levels of chromogranin-A, prostate-specific antigen, and insulin-like growth factor-1 in advanced prostate cancer patients. in The Prostate / Prostate. 2001 May 15;47(3):205-11. doi: 10.1002/pros.1064.
2001
AOU San Luigi di Orbassano
Berruti A; Dogliotti L; Mosca A; Tarabuzzi R; Torta M; Mari M; Gorzegno G; Fontana D; Angeli A;
Metabolic bone disease induced by prostate cancer: Rationale for the use of bisphosphonates in Journal of Urology
2001
AOU San Luigi di Orbassano
Berruti A; Dogliotti L; Tucci M; Tarabuzzi R; Fontana D; Angeli A;
Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline. in The Journal of urology / J Urol. 2000 Oct;164(4):1248-53.
2000
AOU San Luigi di Orbassano
Berruti A; Dogliotti L; Bitossi R; Fasolis G; Gorzegno G; Bellina M; Torta M; Porpiglia F; Fontana D; Angeli A;
Circulating neuroendocrine markers in patients with prostate carcinoma. in Cancer / Cancer. 2000 Jun 1;88(11):2590-7. doi: 10.1002/1097-0142(20000601)88:11<2590::aid-cncr23>3.0.co;2-d.
2000
AOU San Luigi di Orbassano
Berruti A; Dogliotti L; Mosca A; Bellina M; Mari M; Torta M; Tarabuzzi R; Bollito E; Fontana D; Angeli A;
Evaluation by dual energy X-ray absorptiometry of changed bone density in metastatic bone sites as a consequence of systemic treatment. in Oncology reports / Oncol Rep. 2000 Jul-Aug;7(4):777-81. doi: 10.3892/or.7.4.777.
2000
AOU San Luigi di Orbassano
Berruti A; Dogliotti L; Osella G; Cerutti S; Reimondo G; Martino A; Gorzegno G; Catolla R; Angeli A;
Changes in free and free-to-total prostate specific antigen after androgen deprivation or chemotherapy in patients with advanced prostate cancer. in The Journal of urology / J Urol. 1999 Jan;161(1):176-81.
1999
AOU San Luigi di Orbassano
Berruti A; Dogliotti L; Fasolis G; Mosca A; Tarabuzzi R; Torta M; Mari M; Fontana D; Angeli A;
Differential patterns of bone turnover in relation to bone pain and disease extent in bone in cancer patients with skeletal metastases. in Clinical chemistry / Clin Chem. 1999 Aug;45(8 Pt 1):1240-7.
1999
AOU San Luigi di Orbassano
Berruti A; Dogliotti L; Gorzegno G; Torta M; Tampellini M; Tucci M; Cerutti S; Frezet MM; Stivanello M; Sacchetto G; Angeli A;
Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study. in Cancer chemotherapy and pharmacology / Cancer Chemother Pharmacol. 1998;41(4):333-8. doi: 10.1007/s002800050747.
1998
AOU San Luigi di Orbassano
ASL Biella
ASL Cuneo 2
Dogliotti L; Danese S; Berruti A; Zola P; Buniva T; Bottini A; Richiardi G; Moro G; Farris A; Baù MG; Porcile G;
Cytotoxic and antiproliferative activity of the CMF regimen administered in association with tamoxifen as primary chemotherapy in breast cancer patients in International Journal of Oncology
1998
AOU San Luigi di Orbassano
Bottini A; Berruti A; Bersiga A; Brunelli A; Brizzi MP; Di Marco B; Cirillo F; Tampellini M; Bolsi G; Aguggini S; Betri E; Filippini L; Bertoli A; Alquati P; Dogliotti L;
Pamidronate administration improves the secondary hyperparathyroidism due to "Bone Hunger Syndrome" in a patient with osteoblastic metastases from prostate cancer. in The Prostate / Prostate. 1997 Dec 1;33(4):252-5. doi: 10.1002/(sici)1097-0045(19971201)33:4<252::aid-pros5>3.0.co;2
1997
AOU San Luigi di Orbassano
Berruti A; Sperone P; Fasolis G; Torta M; Fontana D; Dogliotti L; Angeli A;
Biochemical picture of bone metabolism in breast cancer patients with bone metastases. in Anticancer research / Anticancer Res. 1995 Nov-Dec;15(6B):2871-5.
1995
AOU San Luigi di Orbassano
Berruti A; Torta M; Piovesan A; Raucci CA; Orlandi F; Panero A; Dogliotti L; Angeli A;
Cytotoxic chemotherapy for adrenocortical carcinoma. in Minerva endocrinologica / Minerva Endocrinol. 1995 Mar;20(1):105-9.
1995
AOU San Luigi di Orbassano
Dogliotti L; Berruti A; Pia A; Paccotti P; Alì A; Angeli A;
Acute myeloblastic leukemia associated with mediastinal nonseminomatous germ cell tumors. Report on two cases. in Tumori / Tumori. 1995 Jul-Aug;81(4):299-301.
1995
AOU San Luigi di Orbassano
Berruti A; Pazè E; Fara E; Gorzegno G; Dogliotti L;
Third-line chemotherapy with mitomycin C and lonidamine in advanced bladder cancer. Partial response in a patient with skin and lung metastases. in Tumori / Tumori. 1995 Jan-Feb;81(1):39-41.
1995
AOU San Luigi di Orbassano
Berruti A; Gerbino A; Faggiuolo R; Rovero E; Dogliotti L;
Combination chemotherapy with carboplatin and methotrexate in the treatment of advanced urothelial carcinoma. A phase II study. in American journal of clinical oncology / Am J Clin Oncol. 1995 Feb;18(1):78-82. doi: 10.1097/00000421-199502000-00017.
1995
AOU San Luigi di Orbassano
Dogliotti L; Bertetto O; Berruti A; Clerico M; Fanchini L; Sicora W; Faggiuolo R;
Serum levels of carboxyterminal propeptide of type I procollagen in cancer patients with osteoblastic and osteolytic bone metastases. in The International journal of biological markers / Int J Biol Markers. 1994 Oct-Dec;9(4):243-6.
1994
AOU San Luigi di Orbassano
Piovesan A; Berruti A; Osella G; Raucci CA; Torta M; Dogliotti L; Angeli A;
Transient increase in total serum alkaline phosphatase predicts radiological response to systemic therapy in breast cancer patients with osteolytic and mixed bone metastases. in Oncology / Oncology. 1993 Jul-Aug;50(4):218-21. doi: 10.1159/000227182.
1993
AOU San Luigi di Orbassano
Berruti A; Osella G; Raucci CA; Roncari A; Dogliotti L;
Hypertriglyceridemia during long-term interferon-alpha therapy: efficacy of diet and gemfibrosil treatment. A case report. in Tumori / Tumori. 1992 Oct 31;78(5):353-5.
1992
AOU San Luigi di Orbassano
Berruti A; Gorzegno G; Vitetta G; Tampellini M; Dogliotti L;
Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients. in Drugs / Drugs. 1992;43 Suppl 3:6-10. doi: 10.2165/00003495-199200433-00004.
1992
AOU San Luigi di Orbassano
Dogliotti L; Antonacci RA; Pazè E; Ortega C; Berruti A; Faggiuolo R;